N/A N=90

Kinesiophobia in Patients With Fibromyalgia Syndrome and Chronic Neck Pain

Fibromyalgia · Neck Pain · Healthy

Bottom Line

View on ClinicalTrials.gov: NCT03778801 ↗

Enrolled (actual)

Serious AEs

—

Results posted

Jan 2025

Primary outcome: Primary: Tampa Scale of Kinesiophobia — 41.70; 38.33; 30.83 score on a scale

Study Design & Population

Study type: Observational
Phase: N/A
Interventions: kinesiophobia (Diagnostic_test)
Age: Adult, Older Adult · 18+ yrs
Sex: All
Sponsor: Aksaray University Training and Research Hospital
Primary completion: Dec 2018

Outcome Measures

Outcome	Result	p-value
PRIMARY Tampa Scale of Kinesiophobia	41.70; 38.33; 30.83	—
PRIMARY International Physical Activity Questionnaire Short Form	21; 14; 7; 7; 11; 16	—
PRIMARY Beck Depression Inventory	18.37; 12.03; 5.44	—
PRIMARY Fibromyalgia Impact Questionnaire	49.79; 44.44; 13.79	—
PRIMARY Neck Pain Disability Index	49.06; 6.16	—
PRIMARY Visual Analog Scale for the Evaluation of Pain	75.83; 50.33; 0	—
PRIMARY Visual Analog Scale for the Evaluation of Fatigue	74.66; 64.33; 41.66	—

Summary

Kinesiophobia which is described as fear of movement reduces physical activity levels and increases the risk of chronic pain. The investigators consider that kinesiophobia levels are higher in patients with fibromyalgia syndrome and chronic neck pain so that physical activity levels are lower in this patient groups. Because there are not enough studies, the investigators aimed to evaluate kinesiophobia and physical activity levels in this patients.

Eligibility Criteria

Inclusion Criteria

Participants with a clinical diagnosis of fibromyalgia syndrome Participants with a clinical diagnosis of chronic neck pain Healthy participants Participants with fibromyalgia syndrome and chronic neck pain has had a disease duration more than three months

Exclusion Criteria

Malignant disease Systemic infectious disease Rheumatic disease Operation Pregnancy Psychological or cognitive disorder History of physical therapy within the last three months History of intra-articular or intra-ligamentary injection within the last three months

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03778801). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.